Related Experiment Video
Updated: Aug 23, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia
C von Meyenburg1, B H Hrupka, D Arsenijevic
1Institute of Animal Sciences, Swiss Federal Institute of Technology, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland. claudia.vonmeyenburg@inw.agrl.ethz.ch
Abstract:
The cell surface component CD14 and the toll-like receptors 2 and 4 (TLR2 and TLR4) are important in mediating the immune responses to bacterial products in mammals. Using mice genetically deficient in CD14, TLR2, or TLR4, we studied the role of these molecules in the anorectic effects of LPS and muramyl dipeptide (MDP). CD14 or TLR2 knockout (KO) and TLR4-deficient (TLR4-DEF) mice as well as corresponding wild-type (WT) colittermates were injected intraperitoneally at dark onset with LPS (2 microg/mouse), MDP (10 mg/kg), interleukin-1 beta (IL-1 beta, 150 ng/mouse), or vehicle, and food intake was recorded. LPS and MDP reduced food intake in WT mice of all genotypes tested. The anorectic effect of LPS was attenuated (P < 0.04) in CD14-KO and TLR4-DEF mice but not in TLR2-KO (P > 0.05). The anorectic effect of MDP was blunted in CD14-KO and TLR2-KO (P < 0.02) mice but not in TLR4-DEF mice. IL-1 beta reduced food intake similarly in all genotypes tested. These results indicate that CD14 is involved in mediating the anorectic effects of both LPS and MDP. Furthermore, TLR4 and TLR2 are specifically involved in mediating the anorectic effects of LPS and MDP, respectively. The results are consistent with the hypothesis that TLR4 functions as the true LPS receptor and that TLR2 is involved in recognition of gram-positive bacterial products.
Insights
Toll-like receptors (TLR) 4 and TLR2, along with CD14, mediate the appetite-suppressing effects of bacterial components lipopolysaccharide (LPS) and muramyl dipeptide (MDP). TLR4 mediates LPS effects, while TLR2 mediates MDP effects.
Area of Science:
- Immunology
- Neuroscience
- Microbiology
Background:
- CD14, TLR2, and TLR4 are key immune mediators for bacterial products.
- Understanding their role in anorexia is crucial for immune response research.
Purpose of the Study:
- To investigate the specific roles of CD14, TLR2, and TLR4 in mediating the anorectic effects of LPS and MDP.
- To elucidate the receptor-ligand interactions in bacterial-induced appetite suppression.
Main Methods:
- Utilized genetically modified mice (CD14, TLR2, TLR4 knockout/deficient) and wild-type controls.
- Administered LPS, MDP, or IL-1 beta intraperitoneally and monitored food intake.
- Analyzed statistical significance of anorectic responses across genotypes.
Main Results:
- LPS-induced anorexia was attenuated in CD14 and TLR4-deficient mice, but not TLR2-deficient mice.
- MDP-induced anorexia was blunted in CD14 and TLR2-deficient mice, but not TLR4-deficient mice.
- IL-1 beta affected food intake similarly across all genotypes, indicating specific roles for TLRs.
Conclusions:
- CD14 is essential for mediating anorexia induced by both LPS and MDP.
- TLR4 specifically mediates LPS-induced anorexia, supporting its role as the LPS receptor.
- TLR2 specifically mediates MDP-induced anorexia, suggesting its involvement in recognizing Gram-positive bacterial products.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Stringent Response in E. coli
Amebiasis
Inflammatory Bowel Disease III: Crohn's Disease